Ayvazyan Christine entered the industry of Kidney Dialysis Centers in 2008 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 6213993, which describes it as a Kidney Dialysis Centers. For further clarification, the SIC classifies this business under the code 8092 and described it as a Kidney Dialysis Centers. The business provides service to the B2C market.
To acquire more information, please contact Christine Ayvazyan by calling (818) 242-0475 during business hours. You can also write to the business’ Single Location at 1500 South Central Avenue # 221, Glendale, California CA 91204. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Ayvazyan Christine |
Representative: | Christine Ayvazyan |
Place of Business: | 1500 South Central Avenue # 221, Glendale, CA 91204 |
Contact Number: | (818) 242-0475 |
Type of Service: | Kidney Dialysis Centers |
SIC Number: | 8092 |
NAICS Number: | 6213993 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Began: | 2008 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Ayvazyan Christine is a company operating from Los Angeles, California providing professional Kidney Dialysis Centers and relevant B2C variables. It was founded in 2008 and registered with the SIC code 8092 as Kidney Dialysis Centers, and with the NAICS code 6213993 as Kidney Dialysis Centers.
With a current employee count of 1 to 4, Ayvazyan Christine has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Christine Ayvazyan at (818) 242-0475 for related queries, or to locate its Single Location using the coordinates 34.127557,-118.25772.
The Single Location can also be found at the street address 1500 South Central Avenue # 221 in Glendale, California 91204 and can be engaged online through the company website at , the company Twitter , and Facebook page .